These five genes have been linked to both pancreatic cancer and neuroendocrine tumors, particularly CD99, where the loss of it in PanNETs has previously been associated with a worse prognosis [63, 64, 65, 66, 67]. Here, CD99 is linked to neuroendocrine neoplasm.